De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Optomed Oyj Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Juho Himberg

Algemeen directeur

€64.0k

Totale compensatie

Percentage CEO-salaris81.3%
Dienstverband CEOless than a year
Eigendom CEOn/a
Management gemiddelde ambtstermijn5.8yrs
Gemiddelde ambtstermijn bestuur3.8yrs

Recente managementupdates

Recent updates

Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?

Sep 27
Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?

Earnings Update: Here's Why Analysts Just Lifted Their Optomed Oyj (HEL:OPTOMED) Price Target To €6.63

May 11
Earnings Update: Here's Why Analysts Just Lifted Their Optomed Oyj (HEL:OPTOMED) Price Target To €6.63

Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 26% Share Price Boost

May 10
Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 26% Share Price Boost

Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 25% Share Price Boost

Mar 22
Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 25% Share Price Boost

Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Feb 18
Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Market Cool On Optomed Oyj's (HEL:OPTOMED) Revenues

Dec 21
Market Cool On Optomed Oyj's (HEL:OPTOMED) Revenues

Is Optomed Oyj (HEL:OPTOMED) Using Debt In A Risky Way?

Nov 15
Is Optomed Oyj (HEL:OPTOMED) Using Debt In A Risky Way?

Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Aug 09
Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Investors Continue Waiting On Sidelines For Optomed Oyj (HEL:OPTOMED)

Jun 01
Investors Continue Waiting On Sidelines For Optomed Oyj (HEL:OPTOMED)

Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?

Oct 27
Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?

Is Optomed Oyj (HEL:OPTOMED) A Risky Investment?

Apr 23
Is Optomed Oyj (HEL:OPTOMED) A Risky Investment?

Optomed Oyj (HEL:OPTOMED) Has Debt But No Earnings; Should You Worry?

Aug 05
Optomed Oyj (HEL:OPTOMED) Has Debt But No Earnings; Should You Worry?

Analyse CEO-vergoeding

Hoe is Juho Himberg's beloning veranderd ten opzichte van Optomed Oyj's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-€5m

Mar 31 2024n/an/a

-€4m

Dec 31 2023€64k€52k

-€4m

Compensatie versus markt: De totale vergoeding ($USD 70.84K ) Juho } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Finnish markt ($USD 357.92K ).

Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Juho te vergelijken met de prestaties van het bedrijf.


CEO

Juho Himberg (54 yo)

less than a year

Tenure

€64,000

Compensatie

Mr. Juho Himberg is Chief Executive Officer of Optomed Oyj since October 1, 2023. He has served as the CEO of Aidian (former Orion Diagnostica), a leading point-of-care diagnostics company with innovative...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Juho Himberg
Chief Executive Officerless than a year€64.00kgeen gegevens
Seppo Kopsala
Founder20.8yrs€156.00kgeen gegevens
Sakari Knuutti
CFO, Chief Legal Officer & Secretary of the Board5.8yrsgeen gegevensgeen gegevens

5.8yrs

Gemiddelde duur

46yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van OPTOMED is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.8 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Seppo Makinen
Independent Director5.8yrs€19.00k0.062%
€ 56.6k
Reijo Tauriainen
Independent Director5.8yrs€19.00k0.078%
€ 70.9k
Catherine Calarco
Independent Director1.4yrs€19.00k0.017%
€ 15.8k
Petri Salonen
Chairman of the Board18.8yrs€114.00k0.083%
€ 75.1k
Ty Lee
Independent Director1.4yrs€19.00k0.017%
€ 15.8k
Anna Tenstam
Independent Director4.3yrs€19.00k0.037%
€ 33.4k
Robert Chang
Member of International Scientific Advisory Board3.8yrsgeen gegevensgeen gegevens
Nina Hautala
Member of International Scientific Advisory Board3.8yrsgeen gegevensgeen gegevens
Dan Milea
Member of International Scientific Advisory Board3.8yrsgeen gegevensgeen gegevens
Tunde Peto
Member of International Scientific Advisory Board3.8yrsgeen gegevensgeen gegevens
Daniel Ting
Member of International Scientific Advisory Board3.8yrsgeen gegevensgeen gegevens

3.8yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van OPTOMED wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).